US Stock MarketDetailed Quotes

RZLT Rezolute

Watchlist
  • 4.700
  • +0.030+0.64%
Close Oct 11 16:00 ET
  • 4.700
  • 0.0000.00%
Post 20:01 ET
262.86MMarket Cap-3533P/E (TTM)

About Rezolute Company

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its clinical assets include Ersodetug, a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism, and RZ402, an oral plasma kallikrein inhibitor and potential therapy for the chronic treatment of diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

Company Profile

SymbolRZLT
Company NameRezolute
Listing DateNov 9, 2020
Founded2010
CEOMr. Nevan Charles Elam, J.D.
MarketNASDAQ
Employees59
Fiscal Year Ends06-30
Address275 Shoreline Drive,Suite 500
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-206-4507

Company Executives

  • Name
  • Position
  • Salary
  • Nevan Charles Elam, J.D.
  • Acting Chairman of the Board and Chief Executive Officer
  • 973.65K
  • Daron Evans
  • Chief Financial Officer
  • --
  • Dr. Brian Kenneth Roberts, M.D.
  • Chief Medical Officer
  • 738.86K
  • Young-jin Kim
  • Director
  • 33.75K
  • Dr. Wladimir Hogenhuis, M.D.
  • Independent Director
  • 69.00K
  • Philippe Fauchet
  • Independent Director
  • 66.00K
  • Gil M. Labrucherie
  • Independent Director
  • 69.00K
  • Dr. Nerissa C. Kreher, M.D.
  • Independent Director
  • 62.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data